{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:27:11Z","timestamp":1789396031953,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100018557","name":"Science and Technology Project of Nantong City","doi-asserted-by":"publisher","award":["HS2014014"],"award-info":[{"award-number":["HS2014014"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.yexmp.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T02:44:16Z","timestamp":1465526656000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["c-Yes enhances tumor migration and invasion via PI3K\/AKT pathway in epithelial ovarian cancer"],"prefix":"10.1016","volume":"101","author":[{"given":"Yunfeng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changying","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-7995","authenticated-orcid":false,"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"QinghuaXi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2016.06.002_bb0005","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.3748\/wjg.v12.i35.5743","article-title":"Activation of c-Yes in hepatocellular carcinoma: a preliminary study","volume":"12","author":"Feng","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0010","first-page":"1397","article-title":"Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases","volume":"2","author":"Han","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ijc.21383","article-title":"Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells","volume":"118","author":"Hirsch","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2016.06.002_bb0020","first-page":"880","article-title":"In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)","volume":"6","author":"Hu","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccr.2008.02.003","article-title":"Yes and PI3K bind CD95 to signal invasion of glioblastoma","volume":"13","author":"Kleber","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2016.06.002_bb0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fonc.2013.00296","article-title":"Current status and evolution of preclinical drug development models of epithelial ovarian cancer","volume":"3","author":"Konstantinopoulos","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1756-9966-29-116","article-title":"Elevated c-Src and c-Yes expression in malignant skin cancers","volume":"29","author":"Lee","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0040","first-page":"2627","article-title":"c-Yes tyrosine kinase activity in human colon carcinoma","volume":"8","author":"Park","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2016.06.002_bb0045","first-page":"1","article-title":"Natural inhibitors of PI3K\/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action","volume":"93C","author":"Safdari","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0050","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3892\/or.2012.2010","article-title":"Yes is a central mediator of cell growth in malignant mesothelioma cells","volume":"28","author":"Sato","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","article-title":"PIK3CA is implicated as an oncogene in ovarian cancer","volume":"21","author":"Shayesteh","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jsbmb.2005.09.002","article-title":"The c-Yes 3\u2032-UTR contains adenine\/uridine-rich elements that bind AUF1 and HuR involved in mRNA decay in breast cancer cells","volume":"97","author":"Sommer","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0070","series-title":"ERBB3 Independent Activation of the PI3K Pathway in EGFR Mutant Lung Adenocarcinomas","author":"Song","year":"2015"},{"key":"10.1016\/j.yexmp.2016.06.002_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1023772912750","article-title":"Src family kinases in tumor progression and metastasis","volume":"22","author":"Summy","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001090","article-title":"The naturally processed CD95L elicits a c-yes\/calcium\/PI3K-driven cell migration pathway","volume":"9","author":"Tauzin","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","article-title":"Cellular functions regulated by Src family kinases","volume":"13","author":"Thomas","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/gyno.2002.6851","article-title":"Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers","volume":"88","author":"Wiener","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexmp.2016.06.002_bb0095","series-title":"The Expression of CDK1 Is Associated With Proliferation and Can Be a Prognostic Factor in Epithelial Ovarian Cancer","author":"Xi","year":"2015"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016301095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016301095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T13:40:06Z","timestamp":1617457206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480016301095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0014480016301095"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2016.06.002","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-Yes enhances tumor migration and invasion via PI3K\/AKT pathway in epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}